US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.99

-0.3148-0.76%

Post-market: 40.990.00000.00%16:10 EDT

Volume:44.88K

Turnover:1.84M

Market Cap:204.13M

PE:- -

High:41.42

Open:41.36

Low:40.84

Close:41.30

52wk High:47.00

52wk Low:29.28

Shares:4.98M

Float Shares:4.98M

Volume Ratio:1.33

T/O Rate:0.90%

Dividend:0.02

Dividend Rate:0.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Roche to Move Quickly Toward Filing for Approval of New Autoimmune Drug

Roche is Becoming More Productive

Roche’s Genentech reports ‘positive’ results from Phase 3 Imagination study

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

European Pharma Leaders Push for National Reforms to Boost Investment

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Roche Stock (RHHBY) Rises as New Obesity Drug Promises to Slash Weight By a Fifth

Roche Obesity Drug Candidate Adds to Positive Data with New Trial Results

Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site

MT Newswires Live

Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston

THOMSON REUTERS

Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo

THOMSON REUTERS

Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/CANC/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CANC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","market":"US","secType":"STK","nameCN":"TEMA ONCOLOGY ETF","latestPrice":40.99,"timestamp":1790971200000,"preClose":41.3048,"halted":0,"volume":44883,"hourTrading":{"tag":"盘后","latestPrice":40.99,"preClose":40.99,"latestTime":"16:10 EDT","volume":10,"amount":409.9,"timestamp":1790971805301,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007621390250043535,"floatShares":4980000,"shares":4980000,"eps":0,"marketStatus":"Market Closed","change":-0.3148,"latestTime":"10-02 16:00:00 EDT","open":41.36,"high":41.42,"low":40.84,"amount":1840082,"amplitude":0.014042,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1692158400000,"exchange":"NASDAQ","adjPreClose":41.3048,"sharesOutstanding":4310000,"nav":41.22,"aum":205275600,"dividendRate":0.000478,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.99,"preClose":40.99,"latestTime":"16:10 EDT","volume":10,"amount":409.9,"timestamp":1790971805301,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3307735669687237},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANC\",,,,,undefined,":{"symbol":"CANC","floatShares":4980000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.3307735669687237,"shares":4980000,"dividePrice":0.0196,"high":41.42,"amplitude":0.014042,"preClose":41.3048,"low":40.84,"week52Low":29.28,"pbRate":"--","week52High":47,"institutionHeld":0,"latestPrice":40.99,"eps":0,"divideRate":0.000478,"volume":44883,"delay":0,"ttmEps":0,"open":41.36,"prevYearClose":34.7203,"prevWeekClose":41.5315,"prevMonthClose":42.01,"prevQuarterClose":42.01,"fiveDayClose":41.5315,"twentyDayClose":44.3614,"sixtyDayClose":42.439},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANC\",params:#limit:5,,,undefined,":[{"date":"2025-12-10","symbol":"CANC","amount":0.0195905,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-11","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-11"},{"date":"2024-12-11","symbol":"CANC","amount":0.72827,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-11","defaultRemindTime":1733927400000,"name":"TEMA ONCOLOGY ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-12-11","currency":"USD","dateTimestamp":1733893200000,"payDate":"2024-12-12"},{"date":"2023-12-13","symbol":"CANC","amount":0.149112,"announcedDate":"2023-12-12","type":"dividend","market":"US","newRecordDate":"2023-12-14","defaultRemindTime":1702477800000,"name":"TEMA ONCOLOGY ETF","recordDate":"2023-12-15","payableDate":"2023-12-14","currency":"USD","dateTimestamp":1702443600000,"payDate":"2023-12-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-13","recordDate":"2023-12-14","paymentDate":"2023-12-15","value":0.149112,"currency":"USD"},{"executeDate":"2024-12-11","recordDate":"2024-12-11","paymentDate":"2024-12-12","value":0.72827,"currency":"USD"},{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-11","value":0.0195905,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANC\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669481087","title":"Roche to Move Quickly Toward Filing for Approval of New Autoimmune Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669481087","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669481087?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:18","pubTimestamp":1790173080,"startTime":"0","endTime":"0","summary":"1418 GMT - Roche Holding is expected to move quickly to file for an accelerated approval for its sefaxersen drug candidate, a direct competitor to Novartis's Fabhalta, RBC Capital Markets analysts say. The Swiss drugmaker reported positive interim results for a late-stage study of sefaxersen in autoimmune disease IgA nephropathy and the company had previously said it hoped the data would lead to an accelerated approval, consistent with the Fabhalta precedent, RBC says. \"We think the muted reaction in [Roche] shares downplays the impact of a positive early interim readout from this study in an indication where we model [1.5 billion Swiss francs] in 2034 sales,\" the analysts say in a research note. Nevertheless, the study results reduce the risk on that estimate and bode well for the Swiss drugmaker's pipeline, they add. Shares rise 0.8%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Roche to Move Quickly Toward Filing for Approval of New Autoimmune Drug","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHHBY","HRTS","03165","BK4007","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486556","title":"Roche is Becoming More Productive","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486556","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486556?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:44","pubTimestamp":1790167440,"startTime":"0","endTime":"0","summary":"1244 GMT - Roche Holding is showing signs of improving its research-and-development productivity, Berenberg analysts say in a research note. The returns on the Swiss drugmaker's research-and-development investments this year are on track to reach 10%, above the 9% bar that is the average of both the sector as a whole and the company's own historic track record, Berenberg says, citing its own analysis. \"Roche's valuation reflects this improved pipeline outlook,\" the analysts say. Shares fall 0.5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRTS","CANC","03165","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669227102","title":"Roche’s Genentech reports ‘positive’ results from Phase 3 Imagination study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669227102","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669227102?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:55","pubTimestamp":1790157312,"startTime":"0","endTime":"0","summary":"Genentech, a member of the Roche (RHHBY) Group, announced positive prespecified interim results from the ongoing Phase III Imagination study evalua...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roches-genentech-reports-positive-results-from-phase-3-imagination-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roches-genentech-reports-positive-results-from-phase-3-imagination-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","RHHBY","HRTS","03165","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177534","title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177534?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:21","pubTimestamp":1790151673,"startTime":"0","endTime":"0","summary":"UPDATE 1-Novo Nordisk open to direct New York listing, CEO Doustdar tells FTSept 23 (Reuters)-Novo NordiskNOVOb.COis open to considering a direct New York Stock Exchange listing, replacing the America","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F05A:2","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PJP","LU1623119135.USD","RXL","TRUH","LU0640476718.USD","LU2471134796.USD","XLV","BK4534","IXJ","LU2168564065.EUR","NVOH","IHE","PPH","LU0354030511.USD","NVOX","WDNA","AGNG","HRTS","LLYZ","TMED","MEDI","LU0345770308.USD","THNR","LU0320765992.SGD","GDOC","FTXH","IE00BJJMRY28.SGD","NVO","NVOC","FHLC","IE0009355771.USD","ILDR","LU1023059063.AUD","MHIP","LU1868836591.USD","LU0114720955.EUR","CANC","CURE","OZEM","VHT","IYH","JDOC","LU2028103732.USD","LU0133085943.USD","LU2462157665.USD","IE00BFTCPJ56.SGD","SGXZ99366536.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120310","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120310","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120310?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:00","pubTimestamp":1790114446,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL64Mcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","RVMD","IDNA","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","PTH","BK4139","CANC","IE0009354923.USD","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669712314","title":"Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669712314","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669712314?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:27","pubTimestamp":1790090820,"startTime":"0","endTime":"0","summary":"Roche Holding said an obesity drug candidate met the main objectives of a midstage clinical trial by helping patients reduce their blood glucose and body weight.The Swiss pharmaceutical company is see","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","CANC","THNR","BK4599","VKTX","BK4007","BK4585","OZEM","RHHBY","BK4139","HRTS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123543","title":"Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123543?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:11","pubTimestamp":1790089860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LLY/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0385154629.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU2089284900.SGD","LU2491050154.USD","LU2461242641.AUD","AGNG","IE0004445015.USD","IE00B1BXHZ80.USD","LU0198837287.USD","LU2237438978.USD","LU2264538146.SGD","LU0079474960.USD","LU1988902786.USD","LU1548497426.USD","BK4516","IE0005OL40V9.USD","LU0823416689.USD","LU1093756168.USD","SGXZ31699556.SGD","LU1974910355.USD","LU0672654240.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU2237443895.HKD","LU2213496289.HKD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU1979441026.SGD","LU2168564149.EUR","SG9999013999.USD","SG9999001176.SGD","LU0096364046.USD","IE00B775H168.HKD","IE0004445239.USD","LU0256863902.USD","LU1127390331.HKD","LU1814569148.SGD","LU1720051108.HKD","LU1868836591.USD","IE00BWXC8680.SGD","LU0109394709.USD","LU2023251221.USD","LU2271345857.HKD","PJP","LU2491050071.SGD","SGXZ57979304.SGD","ELIS","LU1720051017.SGD","ELIL","LU0266013472.USD","LU0787776722.HKD","SG9999014898.SGD","LU2168564065.EUR","LU0106261372.USD","LU2106854487.HKD","FHLC","LU0345770993.USD","LU1868836914.USD","LU1267930730.SGD","CANC","IE0001KFT4U8.USD","GB00BDT5M118.USD","LU0471298777.SGD","LU1323610961.USD","IE00B4R5TH58.HKD","WDNA","LU1232071149.USD","LU0158827948.USD","TRUH","THNR","LU0320765992.SGD","MEDI","IE00BFTCPJ56.SGD","LU2357305700.SGD","LU2750360997.AUD","SGXZ51526630.SGD","LU2552382132.HKD","LLYZ","LU2168564495.EUR","LU2237443382.USD","LU2462591350.SGD","LU0432979614.USD","VHT","IE00BFSS7M15.SGD","IE00B1XK9C88.USD","IE00BJJMRX11.SGD","LU1069344957.HKD","LU1868837300.USD","SG9999017495.SGD","IHE","LU2236285917.USD","LU1057294990.SGD","LU0094547139.USD","LU0345770308.USD","LU0174119429.USD","LU0354030438.USD","SG9999001176.USD","LU2237443978.SGD","LU0122379950.USD","LU2063271972.USD","SG9999015986.USD","LU1804176565.USD","LU0689472784.USD","LU2087625088.SGD","BK4581","LU1366192091.USD","LU2168564222.USD","LU2237443465.HKD","BK4588","LLII","LU0823434740.USD","SG9999018857.SGD","SG9999014914.USD","LU0316494557.USD","LU1023059063.AUD","IE0009355771.USD","JDOC","LU2471134952.CNY","IE00B2B36J28.USD","LU0889565916.HKD","LU2111349929.HKD","LU2468319806.SGD","LLYX","LU2602419157.SGD","IE00BKPKM429.USD","LU0061475181.USD","LU0203201768.USD","LU0820561909.HKD","LU0456855351.SGD","LU1551013425.SGD","LU2023250504.SGD","LU2265009873.SGD","LU0238689110.USD","LU0471298694.HKD","TMED","LU2750360641.GBP","LU2746668461.USD","LU1291159041.SGD","LU0820562030.AUD","LU2361044865.SGD","SGXZ99366536.SGD","LU1983299246.USD","LU0320765059.SGD","LU2237443549.SGD","LU0097036916.USD","LU1280957306.USD","LU0289739699.SGD","HRTS","LU0006306889.USD","IXJ","LU2089984988.USD","LLY","SG9999018865.SGD","ILDR","LU2237443622.USD","IE00BJT1NW94.SGD","LU0354030511.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LU1035775433.USD","LU2361045086.USD","SG9999014906.USD","LU0708995401.HKD","LU0943347566.SGD","SG9999015978.USD","LU0417517546.SGD","LU0882574055.USD","LU0882574139.USD","LU1868836757.USD","XLV","LU0353189680.USD","LU2456880835.USD","LU1551013342.USD","LU2211815571.USD","GDOC","LU1623119135.USD","LU2028103732.USD","IE00BN29S564.USD","LU2112291526.USD","LU1629891620.HKD","LU0323591593.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU2552382215.SGD","LU1868837136.USD","LU0683600562.USD","LU2089283258.USD","LU0256863811.USD","LU2552382058.USD","OZEM","BK4585","RXL","LU0786609619.USD","LU0109391861.USD","LU0353189763.USD","LU2324357040.USD","LU2168563687.JPY","FTXH","LU2491049909.HKD","LU0203202063.USD","LU2360106947.USD","IYH","LU0210536198.USD","LU0133085943.USD","LU0225283273.USD","LU0964807845.USD","IE0002141913.USD","LU2471134796.USD","LU0466842654.USD","MEDX","IE00BFSS8Q28.SGD","LU0058720904.USD","LU2023250330.USD","LU0823434583.USD","LU1691799644.USD","LU0820561818.USD","LU2756315318.SGD","BK4533","LU2417539215.USD","LU1061106388.HKD","CURE","LU2896262040.SGD","BK4007","LU2108987350.USD","IE00BKDWB100.SGD","LU2361044949.HKD","LU2471134523.USD","LU2471134879.HKD","PPH","SGXZ81514606.USD","BK4599","LU2746668974.SGD","SG9999015945.SGD","SG9999014880.SGD","LU0158827781.USD","LU1712237335.SGD","LU1064131342.USD","LU1917777945.USD","IE00BK4W5L77.USD","SG9999015952.SGD","LU1989771016.USD","LU2756315664.SGD","LU0114720955.EUR","MHIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140420","title":"European Pharma Leaders Push for National Reforms to Boost Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140420?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:14","pubTimestamp":1790086440,"startTime":"0","endTime":"0","summary":"Several drugmakers urged European authorities to increase health budgets and speed up approvals for new medicines, warning the region is losing out to the U.S. and China in the race to attract investm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LU0889565916.HKD","LU2237443382.USD","IE00BFXG1179.USD","IE0002141913.USD","BK4532","LU0211331839.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU1267930573.SGD","BK4599","NVOH","RHHBY","THNR","LU2236285917.USD","LU2462157665.USD","PPH","IE00BKVL7J92.USD","LU0109394709.USD","BK4007","IE00B2B36J28.USD","LU2237443549.SGD","LU2237443465.HKD","LU2237443622.USD","SNY","LU2237443978.SGD","LU1093756325.SGD","IE00BZ1G4Q59.USD","OZEM","BK4568","LU0058720904.USD","LU0154236417.USD","NVOC","AZN","LU2089984988.USD","BK4585","LU0029864427.USD","LU0708994859.HKD","LU1829250122.USD","LU2237443895.HKD","LU0070302665.USD","LU0128525929.USD","LU2417539215.USD","LU2456880835.USD","03165","LU2468319806.SGD","IE00BJJMRZ35.SGD","GSK","LU0432979614.USD","LU1093756168.USD","BK4588","NVS","LU0208291251.USD","CANC","LU0289739699.SGD","GSK.UK","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4578","NVOX","IE00B4R5TH58.HKD","HRTS","NVO","AZNH","IE0009355771.USD","LU0310800379.SGD","GSKH","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142790","title":"Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142790","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142790?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:47","pubTimestamp":1790084874,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now, emerging competitors could soon challenge their...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Viking Therapeutics Stock Surges. It Could Challenge Lilly and Novo's Obesity Empire","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1988902786.USD","LU2211815571.USD","LU1145028129.USD","SG9999015952.SGD","LU0234572021.USD","LU2462157665.USD","LU2168564495.EUR","LU2468319806.SGD","LU2112291526.USD","LU1035775433.USD","LU0225283273.USD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU2750360997.AUD","LU1629891620.HKD","LU1064131342.USD","PJP","CANC","LU2471134879.HKD","VKTX","IE00BJJMRY28.SGD","LU0094547139.USD","LU1232071149.USD","LU2168564065.EUR","LU2462591350.SGD","LU2471134523.USD","LU2089284900.SGD","LU1868836591.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","IE00BJLML261.HKD","LU2271345857.HKD","LU1069344957.HKD","OZEM","IE0009355771.USD","NVOC","LU0354030511.USD","LU0158827781.USD","LU0320765059.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1280957306.USD","LU2756315318.SGD","LU1720051017.SGD","MEDX","LU1551013425.SGD","LU0417517546.SGD","LU1366192091.USD","LLYZ","LU1868836914.USD","LU2746668974.SGD","LU0097036916.USD","LU0006306889.USD","IE00BKVL7J92.USD","JDOC","LU2417539215.USD","LU0158827948.USD","LU0964807845.USD","LU0323591593.USD","BK4532","LU0203201768.USD","ELIS","LU2552382058.USD","LU1093756325.SGD","BK4599","SG9999015978.USD","LU0943347566.SGD","LU2063271972.USD","LU0471298777.SGD","LU2456880835.USD","LU2023250330.USD","LU1551013342.USD","LU2491049909.HKD","LU0471298694.HKD","LU2360106947.USD","LU0882574055.USD","LU0786609619.USD","LU0256863902.USD","LU0823434740.USD","LU1983299246.USD","RXL","LU0708995401.HKD","IE00BN29S564.USD","IE0005OL40V9.USD","LU2602419157.SGD","LU1989771016.USD","LU2237438978.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","IE00BKDWB100.SGD","IYH","LU2106854487.HKD","IE00BKPKM429.USD","SGXZ57979304.SGD","SG9999018857.SGD","LU2023250504.SGD","LU0456855351.SGD","LU0122379950.USD","LU0320765992.SGD","MHIP","BK4534","LU1712237335.SGD","LLII","IE00BJJMRX11.SGD","LU0106261372.USD","LU0289739699.SGD","LU1868837136.USD","LU0096364046.USD","LU1623119135.USD","IE0004445015.USD","LU2265009873.SGD","LU2357305700.SGD","WDNA","SG9999018865.SGD","IHE","LU0198837287.USD","IE00B7KXQ091.USD","NVO","SGXZ81514606.USD","XLV","SG9999001176.SGD","LU2750360641.GBP","TRUH","LU0061475181.USD","LU0109394709.USD","HRTS","SG9999015945.SGD","SG9999017495.SGD","LU0133085943.USD","VHT","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1291159041.SGD","LU1023059063.AUD","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","LU2237443465.HKD","AGNG","BK4139","LU0820561818.USD","LU2237443622.USD","LU0154236417.USD","NVOX","LU0889565916.HKD","LU0210536198.USD","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999014880.SGD","LU2236285917.USD","PPH","IE00BFSS7M15.SGD","LU1093756168.USD","IE0002141913.USD","LU1979441026.SGD","LU0354030438.USD","LU0683600562.USD","LU2087625088.SGD","ILDR","LU0882574139.USD","LU2491050154.USD","LU2896262040.SGD","LU0114720955.EUR","LU1548497426.USD","LU2237443549.SGD","LU2237443978.SGD","LU2361044949.HKD","LU2237443382.USD","LU1061106388.HKD","LU0820561909.HKD","BK4533","LU2213496289.HKD","SG9999014906.USD","LU2028103732.USD","LLYX","SG9999015986.USD","LU0079474960.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2111349929.HKD","LU0316494557.USD","LU0238689110.USD","LU0058720904.USD","LU0203202063.USD","THNR","LU2168564222.USD","LU0787776722.HKD","GDOC","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0353189763.USD","LU1917777945.USD","MEDI","SG9999001176.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU0266013472.USD","LU2471134796.USD","LU2552382215.SGD","TMED","BK4516","FTXH","LU2361044865.SGD","SG9999014898.SGD","SG9999014914.USD","LU1868837300.USD","LU2023251221.USD","IE0004445239.USD","NVOH","CURE","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1720051108.HKD","BK4007","LU0174119429.USD","LU2746668461.USD","LU1868836757.USD","ELIL","IE0001KFT4U8.USD","LU0385154629.USD","LU0345770993.USD","LU0689472784.USD","BK4581","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2168563687.JPY","LU1267930730.SGD","LU2168564149.EUR","BK4588","LU2089283258.USD","LU0640476718.USD","LU0345770308.USD","LU2089984988.USD","LU2471134952.CNY","LU2461242641.AUD","LU2324357040.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","LU0823434583.USD","LLY","LU1974910355.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669472461","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669472461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669472461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lill...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pyxis-oncology-pyxs-moderna-mrna-and-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN29S564.USD","LU0174119429.USD","LU1291159041.SGD","LU2896262040.SGD","IXJ","LU2023250504.SGD","LU2023251221.USD","BK4588","IE00BFSS7M15.SGD","LU2111349929.HKD","SG9999015986.USD","LU2237443549.SGD","LU1988902786.USD","GNOM","LU1548497426.USD","SGXZ81514606.USD","ELIL","LU1551013425.SGD","LU2461242641.AUD","LU1868836914.USD","LU2552382132.HKD","LU0787776722.HKD","BK4516","LU0096364046.USD","LU1868837136.USD","GDOC","LU2063271972.USD","IE0004445015.USD","SG9999013999.USD","LU0471298777.SGD","LU2271345857.HKD","LU2211815571.USD","LU0109391861.USD","LU0471298694.HKD","LU0820562030.AUD","LU2264538146.SGD","LU2265009873.SGD","LU0061475181.USD","LU1868836591.USD","LU2462157665.USD","IE00BK4W5L77.USD","LU2756315318.SGD","IDNA","IE0009355771.USD","LLII","LU0238689110.USD","LU1093756168.USD","SGXZ99366536.SGD","LU2471134796.USD","LU1323610961.USD","LU1061106388.HKD","LU0320765992.SGD","LU2237443382.USD","SG9999018865.SGD","LU1366192091.USD","IE00BKPKM429.USD","LU2089283258.USD","LU0354030438.USD","LU2324357040.USD","SG9999018857.SGD","LU2361044865.SGD","GB00BDT5M118.USD","MRNA","LU0225283273.USD","LU0203202063.USD","LU0210536198.USD","LU1035775433.USD","MRNY","LU1145028129.USD","SGXZ31699556.SGD","IE00B4R5TH58.HKD","BK4532","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU0106261372.USD","BK4139","LU0708995401.HKD","IE00B775H168.HKD","LU2236285917.USD","WDNA","LU0882574055.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2112291526.USD","LU2491050071.SGD","SG9999001176.SGD","SG9999014898.SGD","LU0345770993.USD","ELIS","HRTS","MRNX","LLY","LU0882574139.USD","MEDX","IE0001KFT4U8.USD","LU0114720955.EUR","LU1974910355.USD","BK4501","LU2602419157.SGD","BK4533","CANC","SG9999001176.USD","LU2471134523.USD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU0385154629.USD","LU2237443895.HKD","BK4581","LU0823434583.USD","FTXH","LU0158827948.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU1712237335.SGD","SGXZ57979304.SGD","RXL","LLYZ","SG9999015978.USD","LU2028103732.USD","LU0006306889.USD","LU0345770308.USD","IE00B2B36J28.USD","JDOC","LU2023250330.USD","LGHT","LU2168563687.JPY","LU2417539215.USD","LU2746668461.USD","PPH","LU1989771016.USD","MHIP","LU2468319806.SGD","BK4568","LU0456855351.SGD","LU2213496289.HKD","LU2361045086.USD","LU0234572021.USD","BK4551","BK4585","LLYX","ILDR","LU0466842654.USD","LU0079474960.USD","LU1623119135.USD","LU2456880835.USD","AGNG","LU1232071149.USD","LU2087625088.SGD","LU0316494557.USD","LU0353189680.USD","LU0786609619.USD","PJP","SG9999014914.USD","LU2168564222.USD","TRUH","LU0683600562.USD","CURE","LU0823416689.USD","FHLC","LU0266013472.USD","LU0640476718.USD","LU0964807845.USD","IE00BKDWB100.SGD","LU1720051108.HKD","IHE","IE0005OL40V9.USD","LU2089284900.SGD","LU1057294990.SGD","LU2360106947.USD","SG9999017495.SGD","IE00BWXC8680.SGD","LU0133085943.USD","SG9999014906.USD","BK4007","LU0320765059.SGD","LU0823434740.USD","LU2746668974.SGD","LU0943347566.SGD","LU1093756325.SGD","PYXS","LU2491049909.HKD","LU2361044949.HKD","LU2108987350.USD","LU0323591593.USD","LU0097036916.USD","LU0198837287.USD","LU0672654240.SGD","IE00BFSS8Q28.SGD","BK4599","LU1069344957.HKD","LU1804176565.USD","LU1868836757.USD","LU2168564495.EUR","LU1551013342.USD","LU2756315664.SGD","LU2168564065.EUR","TMED","LU0203201768.USD","LU0820561818.USD","LU0889565916.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","LU0820561909.HKD","LU2471134952.CNY","LU1691799644.USD","LU0109394709.USD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU0094547139.USD","LU1023059063.AUD","IE00B1XK9C88.USD","SG9999015952.SGD","IE00B4JS1V06.HKD","LU0122379950.USD","LU1983299246.USD","MEDI","LU2750360997.AUD","LU2552382215.SGD","LU1629891620.HKD","LU2106854487.HKD","SG9999014880.SGD","LU2471134879.HKD","LU2552382058.USD","LU0256863811.USD","IYH","LU2237443978.SGD","LU1917777945.USD","LU2750360641.GBP","LU0353189763.USD","LU2237443465.HKD","LU2237438978.USD","LU0417517546.SGD","LU2237443622.USD","LU1979441026.SGD","LU2491050154.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0058720904.USD","LU0432979614.USD","LU2357305700.SGD","LU2462591350.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","BK4534","OZEM","LU0256863902.USD","BK4548","LU2089984988.USD","THNR","SG9999015945.SGD","VHT","IE00BJJMRZ35.SGD","LU0158827781.USD","LU1280957306.USD","LU0689472784.USD","LU2168564149.EUR","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142751","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082402,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 22 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU0154236417.USD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","IE00BKVL7J92.USD","LU0097036916.USD","LU0708995401.HKD","LU2756315318.SGD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","NVOH","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","NVOC","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","NVOX","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","BK4532","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","NVO","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142210","title":"AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142210","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081700,"startTime":"0","endTime":"0","summary":"Daraxonrasib is an important therapeutic advance, but pancreatic cancer is not a simple disease where one successful targeted drug makes additional therapeutic development unnecessary. We believe Ampligen has the potential to complement and extend therapies such as daraxonrasib by helping to overcome the immune biological barriers that have h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366375/29489/en/aim-immunotech-highlights-ampligen-s-potential-role-in-the-evolving-pancreatic-cancer-treatment-landscape-following-fda-approval-of-revolution-medicines-daraxonrasib.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE0009355771.USD","LU0889565916.HKD","PTH","RVMD","IE00B2B36J28.USD","LU0109394709.USD","BBH","BK4139","IE0002141913.USD","LABU","IDNA","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE0009354923.USD","IE00BJT1NW94.SGD","BK4588","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144047","title":"Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144047?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"New Preclinical PDAC Package for PRP Shows >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Contrasts Mechanism, Breadth, & Development Role Against Erasca’s Phase 1 ERAS-0015 Datase","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366329/0/en/propanc-biopharma-highlights-differentiated-prp-pancreatic-cancer-data-versus-emerging-pan-ras-program-eras-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYTNYN87.SGD","LU0359202008.SGD","IE00B12V2V27.USD","BK4605","LU0109394709.USD","LU1720051017.SGD","PDX","LU2357305700.SGD","TME","ERAS","IE00BYQNZ168.SGD","PPCB","ONX","BK4509","LU1548497426.USD","IDNA","LU2298322129.HKD","LU0269904917.USD","BK4571","BK4585","BK4588","LU2360107325.USD","SG9999011746.SGD","BK4565","IE0002141913.USD","IE0009354923.USD","BK4108","IE00BJT1NW94.SGD","LU1861219969.SGD","LU0509642566.USD","LU1854103824.USD","LU1854104046.USD","ON","BK4531","LU1023057109.AUD","RVMD","LU0724618433.USD","ONG","LU1861220033.SGD","BK4141","BK4535","IE00BFTCPJ56.SGD","LU0320765992.SGD","CANC","01698","BK4139","PTH","BK4512","BK4548","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669445261","title":"Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669445261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669445261?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:22","pubTimestamp":1790079720,"startTime":"0","endTime":"0","summary":"Eli Lilly and Novo Nordisk have been locked in a fierce battle to corner the weight-loss market, and while it is effectively a duopoly now emerging competitors could soon challenge their lead.Seizing ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0787776722.HKD","SG9999018865.SGD","ILDR","BK4516","BK4599","ELIS","LU1983299246.USD","LU2237443622.USD","SGXZ81514606.USD","LU2462157665.USD","LU2168564149.EUR","LU2089284900.SGD","LU2168564065.EUR","03165","LU1623119135.USD","LU2023250330.USD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0256863902.USD","LU2750360641.GBP","SGXZ31699556.SGD","PJP","MEDX","LU0823416689.USD","LU0109391861.USD","IE00BKVL7J92.USD","SG9999017495.SGD","LU1712237335.SGD","RHHBY","LU0006306889.USD","GB00BDT5M118.USD","LU0174119429.USD","LU1291159041.SGD","SG9999013999.USD","LU0786609619.USD","LU2471134879.HKD","LU1232071149.USD","LU1868837300.USD","BK4532","NVOX","SG9999014906.USD","THNR","LU0354030511.USD","LU0154236417.USD","AGNG","IE00B775H168.HKD","LU2471134523.USD","LU2471134796.USD","LU2063271972.USD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014880.SGD","LU2324357040.USD","LU2746668461.USD","LU1551013425.SGD","LU0198837287.USD","LU0061475181.USD","IE00B4JS1V06.HKD","LU1366192091.USD","NVOH","IE00BK4W5M84.HKD","IE0004445015.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU1974910355.USD","LU0097036916.USD","LU2361045086.USD","LU2111349929.HKD","LU2211815571.USD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0203202063.USD","LU2089283258.USD","LU0683600562.USD","LU0820561909.HKD","LU0320765059.SGD","LU1323610961.USD","LU1093756325.SGD","SGXZ57979304.SGD","OZEM","LU2552382215.SGD","LU0820562030.AUD","HRTS","LLYX","LU1548497426.USD","LU0158827781.USD","LU0210536198.USD","LU0079474960.USD","LLII","LU0385154629.USD","IE00BJJMRY28.SGD","CURE","LU1551013342.USD","CANC","LU0466842654.USD","LU1061106388.HKD","LU2357305700.SGD","IHE","LU0417517546.SGD","LU2746668974.SGD","LU0234572021.USD","LU0456855351.SGD","SG9999014898.SGD","LU2360106947.USD","LU0889565916.HKD","LU1280957306.USD","LLY","LU1804176565.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","BK4534","LU1145028129.USD","LU0823434583.USD","LU1023059063.AUD","LU1868836757.USD","LU0289739699.SGD","LU0345770308.USD","LU0820561818.USD","LU1720051108.HKD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","LU2750360997.AUD","XLV","LU0225283273.USD","MEDI","TMED","IE00BFTCPJ56.SGD","LU0943347566.SGD","SG9999015945.SGD","LU2087625088.SGD","BK4588","IE00BK4W5L77.USD","LU0114720955.EUR","LU1035775433.USD","LU2756315664.SGD","LU1267930730.SGD","LU2552382058.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BZ1G4Q59.USD","IE00BJJMRX11.SGD","LU2471134952.CNY","LU0471298777.SGD","LU1868836591.USD","LU2236285917.USD","VHT","LU0094547139.USD","LU1691799644.USD","IE00B4R5TH58.HKD","LU0203201768.USD","LU0238689110.USD","BK4533","LU1917777945.USD","LU0256863811.USD","MHIP","LU2361044949.HKD","LU2237438978.USD","LU2462591350.SGD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LU2089984988.USD","LU2264538146.SGD","LU2491050154.USD","LU1069344957.HKD","JDOC","LU2602419157.SGD","LU2108987350.USD","SG9999001176.USD","LU2112291526.USD","LU1988902786.USD","BK4007","LU2237443382.USD","LU2271345857.HKD","BK4139","IE00BKPKM429.USD","SG9999015986.USD","IYH","FTXH","LU1629891620.HKD","LU2028103732.USD","LU0058720904.USD","LU2213496289.HKD","LU0158827948.USD","LU0640476718.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU1093756168.USD","LU2756315318.SGD","LU0323591593.USD","LU2168564222.USD","IE00BN29S564.USD","WDNA","FHLC","IE0002141913.USD","LU0882574139.USD","SG9999018857.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0354030438.USD","LU0672654240.SGD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","VKTX","LU0689472784.USD","IE00BWXC8680.SGD","LU0106261372.USD","IE0004445239.USD","LU0823434740.USD","SGXZ51526630.SGD","LU0964807845.USD","LU2468319806.SGD","LU2896262040.SGD","PPH","LU2491050071.SGD","LU0109394709.USD","LU0882574055.USD","NVO","LU2456880835.USD","TRUH","LU2237443549.SGD","LU0133085943.USD","NVOC","BK4585","IE00B1BXHZ80.USD","LU1057294990.SGD","IE00BJLML261.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2168563687.JPY","LU2237443978.SGD","LU2023251221.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU1064131342.USD","LU1868837136.USD","RXL","LU1979441026.SGD","LU0096364046.USD","LU0353189763.USD","LU0353189680.USD","SG9999001176.SGD","LU0345770993.USD","LU0320765992.SGD","LU0316494557.USD","LU0471298694.HKD","LU2361044865.SGD","BK4581","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669990146","title":"Roche Stock (RHHBY) Rises as New Obesity Drug Promises to Slash Weight By a Fifth","url":"https://stock-news.laohu8.com/highlight/detail?id=2669990146","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669990146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:49","pubTimestamp":1790074190,"startTime":"0","endTime":"0","summary":"Shares in pharmaceuticals group Roche ($RHHBY) put on around 2% in pre-market trading today after it said that its new expiremental obesity drug co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/roche-stock-rhhby-rises-as-new-obesity-drug-promises-to-slash-weight-by-a-fifth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/roche-stock-rhhby-rises-as-new-obesity-drug-promises-to-slash-weight-by-a-fifth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AGNG","HRTS","RHHBY","CANC","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669811921","title":"Roche Obesity Drug Candidate Adds to Positive Data with New Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2669811921","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669811921?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:50","pubTimestamp":1790059800,"startTime":"0","endTime":"0","summary":"0649 GMT - Roche Holding achieved positive results in a study for its obesity drug candidate enicepatide in adults with diabetes and obesity, building on a previous trial that showed efficacy in obese patients without diabetes, Vontobel's Stefan Schneider says in a research note. Patients with Type 2 diabetes who are either overweight or obese are an inherently difficult-to-treat patient population, the analyst says. The combination of a good proportion of diabetics getting back to normalized glucose levels and achieving sustained weight loss with enicepatide give the drug a competitive profile, Schneider says.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","HRTS","RHHBY","03165","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619560","title":"Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619560","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619560?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:55","pubTimestamp":1790027717,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company  said Monday it has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, that will produce its oral GLP-1 drug Foundayo along with other small-molecule medicines and advanced therapeutics.Lilly said the facility is expected to create more than 600 high-wage jobs and roughly 4,000 construction jobs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","SG9999001176.USD","LU2089984988.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0672654240.SGD","LU2491049909.HKD","LU2602419157.SGD","IHE","IE00B4R5TH58.HKD","LU2468319806.SGD","LU1035775433.USD","LU0320765059.SGD","LU0823434740.USD","BK4534","LU2237438978.USD","LU2111349929.HKD","LU1291159041.SGD","LU0058720904.USD","IXJ","WDNA","LU2023250504.SGD","LU2168564065.EUR","LU1868836914.USD","PPH","XLV","BK4581","CANC","LU2023250330.USD","MEDI","SG9999015986.USD","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU1069344957.HKD","LU0456855351.SGD","LU1988902786.USD","LU0266013472.USD","LU0820561909.HKD","SG9999015978.USD","BK4599","LU1804176565.USD","ILDR","IE0004445015.USD","LU1983299246.USD","ELIS","LU0689472784.USD","LU2471134879.HKD","LU2063271972.USD","LU0323591593.USD","LU2462591350.SGD","LU0345770308.USD","LU2491050071.SGD","LU2750360641.GBP","SGXZ31699556.SGD","TMED","FTXH","LU1232071149.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0683600562.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU0114720955.EUR","LU1127390331.HKD","LU0354030438.USD","LU0133085943.USD","LU2361045086.USD","LU2756315664.SGD","SG9999015952.SGD","LU0882574055.USD","LU0354030511.USD","LU0320765992.SGD","LU0096364046.USD","LU1691799644.USD","LU2237443382.USD","LU2462157665.USD","LU2106854487.HKD","LU0417517546.SGD","BK4588","LU0708995401.HKD","LU0823434583.USD","IE0002141913.USD","LU0943347566.SGD","LU1551013425.SGD","LU2108987350.USD","CURE","GDOC","LU2361044865.SGD","LU1061106388.HKD","LU1868837300.USD","LU2237443549.SGD","BK4516","IE00B4JS1V06.HKD","LU1720051017.SGD","LU0174119429.USD","PJP","LU2112291526.USD","IE0009355771.USD","BK4585","LU0640476718.USD","LU0820562030.AUD","LU2237443895.HKD","IE00BKPKM429.USD","IE00BN29S564.USD","LU2471134523.USD","LU2168563687.JPY","LU2023251221.USD","LU2491050154.USD","LU0109391861.USD","LU2271345857.HKD","LU2264538146.SGD","SG9999018857.SGD","LLYZ","IE00B1BXHZ80.USD","LU0094547139.USD","LU0964807845.USD","SG9999001176.SGD","IE0005OL40V9.USD","LU1093756325.SGD","BK4007","LU2168564495.EUR","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU1093756168.USD","LU2417539215.USD","LU1917777945.USD","LU2168564222.USD","LU0079474960.USD","LU0256863902.USD","LU2089284900.SGD","IE00B775H168.HKD","LU0225283273.USD","LU0122379950.USD","SG9999013999.USD","LU1974910355.USD","IE00BJJMRX11.SGD","IE00BK4W5L77.USD","AGNG","LU1551013342.USD","LU2471134796.USD","LU2357305700.SGD","LU2896262040.SGD","HRTS","LU2324357040.USD","LU2461242641.AUD","LU2265009873.SGD","IE0004445239.USD","LU1023059063.AUD","SG9999014906.USD","LU2746668461.USD","LU1145028129.USD","LU2237443465.HKD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU1548497426.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0109394709.USD","LU1623119135.USD","LU0316494557.USD","LU0203202063.USD","LU2236285917.USD","RXL","LU0345770993.USD","FHLC","LLYX","LU0353189763.USD","LU2168564149.EUR","LU0234572021.USD","LU2361044949.HKD","LU2237443978.SGD","SG9999018865.SGD","SGXZ81514606.USD","SG9999017495.SGD","LU0385154629.USD","LU2087625088.SGD","LU1280957306.USD","LU2746668974.SGD","LU2756315318.SGD","VHT","LU1366192091.USD","THNR","LU0097036916.USD","IE00BKDWB100.SGD","LU0061475181.USD","LU0882574139.USD","LU1868836757.USD","LU2211815571.USD","LU2750360997.AUD","SG9999014914.USD","LU1868836591.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU0466842654.USD","MEDX","LU0786609619.USD","LU1267930730.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","LU0289739699.SGD","LU2471134952.CNY","LU0353189680.USD","LU2552382058.USD","ELIL","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0238689110.USD","LU0158827948.USD","LU0203201768.USD","LU0106261372.USD","LU1057294990.SGD","TRUH","LU0820561818.USD","LU1868837136.USD","LU0823416689.USD","LU2360106947.USD","LU2552382132.HKD","SGXZ99366536.SGD","LU2089283258.USD","LU1629891620.HKD","SG9999015945.SGD","IYH","LU0006306889.USD","IE0001KFT4U8.USD","LU0889565916.HKD","LU1323610961.USD","LU1064131342.USD","BK4533","LU0158827781.USD","LU0210536198.USD","LU1720051108.HKD","LU1979441026.SGD","LU1989771016.USD","LU2456880835.USD","LU0471298777.SGD","LLII","LU0471298694.HKD","LLY","LU1814569148.SGD","LU2552382215.SGD","LU0787776722.HKD","MHIP","OZEM","LU2213496289.HKD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669955941","title":"Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston","url":"https://stock-news.laohu8.com/highlight/detail?id=2669955941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669955941?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:44","pubTimestamp":1790027083,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","IE0001KFT4U8.USD","LU1917777945.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669597195","title":"Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2669597195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669597195?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:44","pubTimestamp":1790027083,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0IB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0158827781.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","IE00BJT1NW94.SGD","BK4581","RXL","SG9999018857.SGD","LU1232071149.USD","LU0823434740.USD","LU0109394709.USD","LU0823434583.USD","LU2271345857.HKD","GB00BDT5M118.USD","LU1127390331.HKD","LU0345770993.USD","LU1979441026.SGD","SG9999015978.USD","IE0005OL40V9.USD","LU1551013342.USD","SG9999015952.SGD","SGXZ99366536.SGD","IE00B2B36J28.USD","SGXZ51526630.SGD","LU1093756168.USD","LU1069344957.HKD","WDNA","LU0320765992.SGD","LU2237443895.HKD","LU1868836591.USD","LU0133085943.USD","FTXH","LU0256863902.USD","BK4007","LU0174119429.USD","LU0323591593.USD","LU2471134523.USD","IE00B4R5TH58.HKD","LU0203201768.USD","CURE","LU1629891620.HKD","LU1804176565.USD","PPH","LU2112291526.USD","IE00B7KXQ091.USD","LU1868836914.USD","SG9999015945.SGD","LU1023059063.AUD","LU0061475181.USD","LU0823416689.USD","AGNG","LU0320765059.SGD","LU2237443978.SGD","LU2023251221.USD","LU2108987350.USD","LU2357305700.SGD","LU2471134796.USD","LU2552382132.HKD","LU0689472784.USD","LU2456880835.USD","LU2602419157.SGD","LU2213496289.HKD","SG9999013999.USD","LU1064131342.USD","LU0096364046.USD","LU0114720955.EUR","SG9999017495.SGD","BK4534","LU0210536198.USD","VHT","LU1548497426.USD","LU0708995401.HKD","LLY","LU2746668461.USD","LU2491050071.SGD","LU1974910355.USD","LU1868837136.USD","THNR","TRUH","LU0094547139.USD","LU2361045086.USD","LU2746668974.SGD","LU1291159041.SGD","LU0266013472.USD","IYH","LU0353189763.USD","LU2471134952.CNY","LU1814569148.SGD","LU0672654240.SGD","LU2089284900.SGD","LU0640476718.USD","LU2491050154.USD","LU2236285917.USD","LLYZ","LU0820562030.AUD","LU2237443465.HKD","LU2468319806.SGD","LU2087625088.SGD","IE00BKDWB100.SGD","IE00BJLML261.HKD","BK4599","LU2750360997.AUD","IE0001KFT4U8.USD","LU1917777945.USD","LU2089283258.USD","LU0238689110.USD","LU0198837287.USD","XLV","LU0289739699.SGD","IE00BFSS7M15.SGD","LU2023250330.USD","LU2168563687.JPY","LU0354030438.USD","LU0882574139.USD","LU0225283273.USD","LU0234572021.USD","LU2756315664.SGD","JDOC","SGXZ31699556.SGD","BK4516","LU0006306889.USD","LU1712237335.SGD","LU2028103732.USD","LU1623119135.USD","LU0786609619.USD","LU2237443622.USD","IE0004445239.USD","LU1035775433.USD","IE0002141913.USD","MHIP","SG9999014898.SGD","LU0353189680.USD","LU0385154629.USD","LU2168564065.EUR","IE00B775H168.HKD","LU0787776722.HKD","LU2111349929.HKD","LU0466842654.USD","IXJ","LU2491049909.HKD","LU2756315318.SGD","MEDX","LU0882574055.USD","LU1366192091.USD","LU2471134879.HKD","LU2264538146.SGD","LU2089984988.USD","LU0079474960.USD","IE00BFTCPJ56.SGD","LU1720051017.SGD","ELIL","FHLC","ELIS","IE0004445015.USD","LU0456855351.SGD","LU2106854487.HKD","LU0354030511.USD","LU2361044949.HKD","IE0009355771.USD","LU1267930730.SGD","SGXZ81514606.USD","LU1280957306.USD","LU2461242641.AUD","OZEM","IHE","LU2168564495.EUR","LU1988902786.USD","LLYX","LU1989771016.USD","LU2237443549.SGD","LU2023250504.SGD","LU0097036916.USD","LU2168564222.USD","LU2324357040.USD","IE00BN29S564.USD","LU2361044865.SGD","LU0471298694.HKD","SG9999018865.SGD","BK4533","LU0106261372.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU1323610961.USD","LU1983299246.USD","LU2462157665.USD","LU2237438978.USD","SG9999014880.SGD","LU2265009873.SGD","IE00BWXC8680.SGD","LU0889565916.HKD","LU1720051108.HKD","LU1868836757.USD","LU2360106947.USD","LU2552382058.USD","LU2063271972.USD","LU0058720904.USD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","PJP","LU2211815571.USD","LU0345770308.USD","SG9999014914.USD","LU2462591350.SGD","TMED","LU0203202063.USD","LU2750360641.GBP","SG9999014906.USD","IE00B4JS1V06.HKD","IE00BJJMRX11.SGD","LU1093756325.SGD","LU2237443382.USD","IE00BK4W5L77.USD","LU2417539215.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1691799644.USD","LU0471298777.SGD","LU1061106388.HKD","LU0109391861.USD","IE00BFSS8Q28.SGD","SG9999015986.USD","LU0316494557.USD","BK4588","HRTS","LU0417517546.SGD","MEDI","LU0820561818.USD","ILDR","LU1551013425.SGD","LU2168564149.EUR","IE00B1XK9C88.USD","GDOC","LU0122379950.USD","LU0158827948.USD","IE00BK4W5M84.HKD","LU0432979614.USD","LU1057294990.SGD","LU0820561909.HKD","BK4585","LU1868837300.USD","SG9999001176.USD","LLII","LU0683600562.USD","LU0964807845.USD","LU2552382215.SGD","LU2896262040.SGD","CANC","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669193392","title":"Nvidia, QIA-Backed Iambic Therapeutics Files for US IPO as Biotech Boom Rolls On","url":"https://stock-news.laohu8.com/highlight/detail?id=2669193392","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669193392?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:38","pubTimestamp":1790023092,"startTime":"0","endTime":"0","summary":"UPDATE 3-Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls onSept 21 (Reuters)-Drug developer Iambic Therapeutics, backed by chip giant NvidiaNVDA.Oand Qatar's sovereign we","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D1EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09388","NVDS.UK","3NVD.UK","ABBV","SNPE","07788","AIPI","FDTX","NVDO","JGRO","2NVD.UK","RVMD","USD","TEK","CHAT","BBH","SHOC","CMAG","SNVD.UK","VHT","DIPS","XLF","SOXX","RXL","ESLG","CLSE","ARTY","TFNS","FHLC","JAZZ","NVII","UYG","NVDG","CANC","BAC","NVDA","SOXY","SPTE","PJP","GAMR","VGT","ABFL","07388","CNEQ","SOXQ","LFGY","VT","CHPX","PPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}